Brief: Trinity Biotech Enters Oncology Space With Acquisition Of Prostate Cancer Focused Epicapture
25/10/2024 14:35
Oct 25 (Reuters) - Trinity Biotech PLC TRIB.O :
* TRINITY BIOTECH ENTERS ONCOLOGY SPACE WITH ACQUISITION OF
PROSTATE CANCER FOCUSED EPICAPTURE
* TRINITY BIOTECH PLC - ACQUIRES EPICAPTURE FOR $3 MILLION
PLUS
$0.5 MILLION CONTINGENT
Source text for Eikon: ID:nGNX43WBZf
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM